Detalles de la búsqueda
1.
Economic impact of a more extensive use of FENO testing on the Italian population with asthma.
Respir Res
; 24(1): 147, 2023 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268938
2.
When peers count: The effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams.
Health Care Manage Rev
; 44(1): 67-78, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-28306609
3.
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy.
Adv Ther
; 41(4): 1385-1400, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329713
4.
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries.
Lancet Glob Health
; 12(1): e156-e165, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096888
5.
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis.
Glob Reg Health Technol Assess
; 10: 1-11, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789180
6.
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy.
Pharmacoeconomics
; 41(2): 209-225, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36662417
7.
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention.
Expert Rev Pharmacoecon Outcomes Res
; 23(9): 1101-1111, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589294
8.
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case.
J Pharm Policy Pract
; 16(1): 67, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198599
9.
Collecting Physicians' Preferences on Medical Devices: Are We Doing It Right? Evidence from Italian Orthopedists Using 2 Different Stated Preference Methods.
Med Decis Making
; 43(7-8): 886-900, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37837325
10.
The Value of Hearing Aids for the Italian NHS: A Cost-utility Analysis.
Otol Neurotol Open
; 2(4): e018, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38516581
11.
The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis.
PLoS One
; 17(5): e0268677, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35594257
12.
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis.
Expert Opin Biol Ther
; 22(12): 1579-1584, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35466843
13.
Digital Twins in Healthcare: Is It the Beginning of a New Era of Evidence-Based Medicine? A Critical Review.
J Pers Med
; 12(8)2022 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36013204
14.
Use of Resource Modeling to Quantify the Organizational Impact of Subcutaneous Formulations for the Treatment of Oncologic Patients: The Case of Daratumumab in Multiple Myeloma.
Clin Ther
; 44(11): 1480-1493, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195503
15.
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal.
Int J Environ Res Public Health
; 18(3)2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530652
16.
Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies.
Health Policy
; 125(5): 602-608, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820679
17.
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).] / Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement).
Recenti Prog Med
; 112(11): 749-756, 2021 11.
Artículo
en Italiano
| MEDLINE | ID: mdl-34782810
18.
Cost-benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With Diet.
Clin Ther
; 42(1): 60-75.e7, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959413
19.
Implementation of Value-based Pricing for Medicines.
Clin Ther
; 42(1): 15-24, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31882225
20.
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
Clin Ther
; 42(5): 830-847, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32354495